Literature DB >> 9801213

Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study.

J J Jacobs1, A K Skipor, L M Patterson, N J Hallab, W G Paprosky, J Black, J O Galante.   

Abstract

UNLABELLED: There is an increasing recognition that, in the long term, total joint replacement may be associated with adverse local and remote tissue responses that are mediated by the degradation products of prosthetic materials. Particular interest has centered on the metal-degradation products of total joint replacements because of the known toxicities of the metal elements that make up the alloys used in the implants. We measured the concentrations of titanium, aluminum, cobalt, and chromium in the serum and the concentration of chromium in the urine of seventy-five patients during a three-year prospective, longitudinal study. Twenty patients had had a so-called hybrid total hip replacement (insertion of a modular cobalt-alloy femoral stem and head with cement and a titanium acetabular cup without cement), fifteen had had insertion of an extensively porous-coated cobalt-alloy stem with a cobalt-alloy head and a titanium-alloy socket without cement, and twenty had had insertion of a proximally porous-coated titanium-alloy stem with a cobalt-alloy head and a titanium socket without cement. The remaining twenty patients did not have an implant and served as controls. The results of our study showed that, thirty-six months postoperatively, patients who have a well functioning prosthesis with components containing titanium have as much as a threefold increase in the concentration of titanium in the serum and those who have a well functioning prosthesis with cobalt-alloy components have as much as a fivefold and an eightfold increase in the concentrations of chromium in the serum and urine, respectively. The predominant source of the disseminated chromium-degradation products is probably the modular head-neck junction and may be a function of the geometry of the coupling. Passive dissolution of extensively porous-coated cobalt-alloy stems was not found to be a dominant mode of metal release. CLINICAL RELEVANCE: Increased concentrations of circulating metal-degradation products derived from orthopaedic implants may have deleterious biological effects over the long term that warrant investigation. This is a particularly timely concern because of recent clinical trends, including the reintroduction of metal-on-metal bearing surfaces and the increasing popularity of extensively porous-coated devices with large surface areas of exposed metal. Accurate monitoring of the concentrations of metal in the serum and urine after total hip replacement also can provide insights into the mechanisms of metal release. Our findings suggest that fretting corrosion at the head-neck coupling is an important source of metal release that can lead to increased concentrations of chromium in the serum. Determinations of the concentrations of metal in the serum and urine may be useful in the diagnosis of patients who are symptomatic after a total joint replacement as increased levels are indicative of at least one mode of mechanical dysfunction (for example, fretting corrosion) of the device.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9801213     DOI: 10.2106/00004623-199810000-00006

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  67 in total

1.  Improved mechanical long-term reliability of hip resurfacing prostheses by using silicon nitride.

Authors:  Wen Zhang; M Titze; B Cappi; D C Wirtz; R Telle; H Fischer
Journal:  J Mater Sci Mater Med       Date:  2010-08-20       Impact factor: 3.896

2.  Serum metal ion levels after rotating-hinge knee arthroplasty: comparison between a standard device and a megaprosthesis.

Authors:  Joerg Friesenbichler; Werner Maurer-Ertl; Patrick Sadoghi; Thomas Lovse; Reinhard Windhager; Andreas Leithner
Journal:  Int Orthop       Date:  2011-07-14       Impact factor: 3.075

3.  Clinical and biological assessment of cemented titanium femoral stems: an 11-year experience.

Authors:  Patrick Boyer; Jean-Yves Lazennec; Joel Poupon; Marc-Antoine Rousseau; Philippe Ravaud; Yves Catonné
Journal:  Int Orthop       Date:  2008-10-28       Impact factor: 3.075

Review 4.  Systemic contact dermatitis and allergy to biomedical devices.

Authors:  Marcella Aquino; Tania Mucci
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

5.  Serum titanium, niobium and aluminium levels two years following instrumented spinal fusion in children: does implant surface area predict serum metal ion levels?

Authors:  Thomas P Cundy; William J Cundy; Georgia Antoniou; Leanne M Sutherland; Brian J C Freeman; Peter J Cundy
Journal:  Eur Spine J       Date:  2014-11       Impact factor: 3.134

6.  Trace metal analysis following locked volar plating for unstable fractures of the distal radius.

Authors:  Lucas S Rylander; Joseph C Milbrandt; Evan Armington; Marty Wilson; David J Olysav
Journal:  Iowa Orthop J       Date:  2010

7.  The role of citrate, lactate and transferrin in determining titanium release from surgical devices into human serum.

Authors:  Justin P Curtin; Minji Wang; Tianfan Cheng; Lijian Jin; Hongzhe Sun
Journal:  J Biol Inorg Chem       Date:  2018-04-05       Impact factor: 3.358

Review 8.  What is the trouble with trunnions?

Authors:  Christina I Esposito; Timothy M Wright; Stuart B Goodman; Daniel J Berry
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

Review 9.  Are clinical findings of systemic titanium dispersion following implantation explained by available in vitro evidence? An evidence-based analysis.

Authors:  Justin Paul Curtin; Minji Wang
Journal:  J Biol Inorg Chem       Date:  2017-05-17       Impact factor: 3.358

10.  Cancer risk is not increased after conventional hip arthroplasty.

Authors:  Tuomo Visuri; Pekka Pulkkinen; Pekka Paavolainen; Eero Pukkala
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.